Rare diseases
Investigational molecules
Locations
Back to Germany978 clinical trials in Frankfurt, Germany across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation
GermanyStudy on the Effectiveness of Autogene Cevumeran in Patients with ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
GermanyLong-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II
GermanyStudy on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure
GermanyStudy of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment
GermanyLong-term Study on Treatment Response in Chronic Hepatitis B Patients Using Bepirovirsen
GermanyStudy Comparing Sonrotoclax and Zanubrutinib with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia
GermanyStudy of Futibatinib with Pembrolizumab and Chemotherapy for Patients with Solid Tumors
GermanyStudy on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis
GermanyStudy of XXB750 and Drug Combination for Patients with Heart Failure
GermanyStudy of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
GermanyStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on hematologic malignancies and solid tumors, including innovative treatments for lymphoma, leukemia, and various gastrointestinal cancers.
Studies evaluate novel therapeutic combinations and targeted treatments to improve patient outcomes.
Research initiatives examining treatments for inflammatory bowel conditions, including Crohn's Disease and Ulcerative Colitis, with emphasis on long-term management approaches.
Focus on innovative therapeutic options for chronic inflammatory conditions.
Clinical investigations of treatments for rare conditions, including Von Willebrand Disease and Dravet Syndrome, exploring novel therapeutic approaches.
Development of targeted therapies for previously difficult-to-treat conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
